Pharma Strategy Blog

Commentary on Pharma & Biotech Oncology / Hematology New Product Development

It is hoped that through the new collaboration with Private Access, the innovator of privacy-enhanced search technology, Pfizer will be able to bolster patient participation in clinical trials. The proposed online community is set to focus on patient privacy rights, connecting patients, physicians and researchers with tailored information, tools and technology that will lead to more informed decisions about healthcare, including clinical trial participation industry-wide. It will be the first of its kind and is being lavished in praise.

Part of the challenge with clinical trial accrual is patient awareness, so it will be interesting to see how this initiative goes and whether or not it will have a positive impact.

Of course, there are plenty of clinical trial resources already out there including the big guns such as  NIH/NCI site and  Center Watch, which have an extensive database of broad diseases or the smaller, niche players such as Healogica and others, but new ways of driving awareness are always welcome.  For interested patients, the Private Access trial finder can ber found here. 

Posted via web from MaverickNY

5 Responses to “Are Pfizer's plans to accelerate clinical research too little?”

  1. Edward Shin

    Thanks for mentioning Healogica ( We’ll be adding new conditions in the next couple of weeks. By the end of the year, we’ll have a comprehensive list of conditions represented in our clinical trial database.
    You can also check out our iphone app:
    Thanks again,

  2. MaverickNY

    Hi Ed, thank you for your comment.
    I’m really glad to hear that you are expanding into other conditions… please stop by again and give us an update, we would love to hear about your progress.

  3. Pharma Ed

    Just had a quick look at the healogica iphone app. Its fantastic to see such an innovative idea, especially in its ease of use for the patient and hopefully it will drive clinical research to an all time high. Really quite exciting to see such technological advancements in the world of pharma.

Comments are closed.

error: Content is protected !!